학술논문
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
Document Type
Article
Author
Sivaprasad, S.; Hykin, P.; Prevost, A.T.; Vasconcelos, J.C.; Riddell, A.; Murphy, C.; Kelly, J.; Bainbridge, J.; Tudor-Edwards, R.; Hopkins, D.; Bhatnagar, A.; Burton, B.; Chakravarthy, U.; Eleftheriadis, H.; Empeslidis, T.; Gale, R.; George, S.; Habib, M.; Kelly, S.; Lotery, A.; McKibbin, M.; Membrey, L.; Menon, G.; Mushtaq, B.; Nicholson, L.; Ramu, J.; Osoba, O.; Patel, J.; Prakash, P.; Purbrick, R.; Ross, A.; Stylianides, A.; Talks, J.; Harding, S.; Peto, T.; Yeo, S.T.; Laidlaw, A.; Amoaku, W.; Hood, G.; Hitman, G.A.; Preece, D.; Burns, P.; Walker, S.; Mensah, E.; Karia, N.
Source
In: The Lancet . (The Lancet, 3 June 2017, 389(10085):2193-2203)
Subject
Language
English
ISSN
1474547X
01406736
01406736